Casdin Capital
Investor profile
Deals
9
distinct rounds
Companies
7
backed
Active span
2020–2025
6 yrs
Total round €
€550M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Illumina Ventures2
- Kurma Partners2
- LSP2
- Agilent Technologies1
- Alexandria Venture Investments1
- Andera Partners1
- Arix Bioscience1
- Arrowmark Partners1
- Bluebird Ventures1
- BNP Paribas Développement1
- Bpifrance Large Venture1
- Brabant Development Agency1
- Byers Capital1
- CaaS Capital Management1
- ClavystBio1
- Columbia Threadneedle Investments1
- Danaher Life Sciences1
- Eurazeo1
- European Investment Bank (EIB)1
- F-Prime Capital1
- Farallon Capital1
- Fidelity Management & Research Company LLC1
- Fidelity Management and Research Company1
- GV1
- GV (Google Ventures)1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Leyden Labs | Netherlands | 2 | €192M |
| DNA Script | France | 2 | €188M |
| T-knife | Germany | 1 | €94M |
| Depixus | France | 1 | €31M |
| Stilla Technologies | France | 1 | €31M |
| InnoSIGN | Netherlands | 1 | €7.3M |
| Loop Medical | Switzerland | 1 | €5.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| Leyden Labs | Series B | €124M | 2022-01 |
| T-knife | Series B | €94M | 2021-08 |
| Leyden Labs | Other | €68M | 2025-01 |
| DNA Script | Series B | €46M | 2020-07 |
| Depixus | Series A | €31M | 2021-12 |
| Stilla Technologies | Other | €31M | 2021-11 |
| InnoSIGN | Series A | €7.3M | 2022-04 |
| Loop Medical | Series A | €5.5M | 2021-10 |